74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Merit Medical Systems Inc
Closed
SectorHealthcare
94.13 0.99
Overview
Share price change
24h
Min
92.92
Max
95.53
Income | 28M |
|---|---|
Sales | 355M |
P/E Sector Avg | 44.138 57.333 |
EPS | 0.93 |
Profit margin | 7.869 |
Employees | 7,400 |
EBITDA | 73M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +24.15% upside |
Market Cap | -909M 5.4B |
|---|---|
Previous open | 93.14 |
Previous close | 94.13 |
Technical Score
By Trading Central
Confidence
Weak Bearish Evidence
Merit Medical Systems Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Merit Medical Systems Inc Forecast
Price Target
By TipRanks
24.15% upside
12 Months Forecast
Average 116.4 USD 24.15%
High 127 USD
Low 111 USD
Based on 10 Wall Street analysts offering 12 month price targets forMerit Medical Systems Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Merit Medical Systems Inc
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
